The role of cystectomy in elderly patients - a multicentre analysis

BJU International
Laura IzquierdoNathan Lawrentschuk

Abstract

Life expectancy in developed countries is continuously increasing. Hence elderly patients are becoming more common in our clinical practice. Currently, one of the greatest challenges of medicine is balancing the life expectancy of elderly patients against aggressive treatments that carry significant risks. To outline the complications and survival in surgical patients 80 years and over undergoing radical cystectomy for bladder cancer. A review of a radical cystectomy in elderly recorded in four different institutional prospective databases during the period between 1991 and 2014. Clinical and pathologic features, complications and survival were evaluated. A total of 111 patients were available. Median (range) age 82.2 (80-89) years. Seventeen women and 94 men. Regarding the ASA score, 6 patients were ASA I, 47 patients were ASA II, 49 patients ASA III and 9 ASA IV. Prior to surgery, 48 patients had hydronephrosis. The median (range) creatinine series was 1.1 (0.71-11.1) ng/dL. In 88 cases an ileal conduit was performed, 17 a cutaneous ureterostomy diversion, 5 neobladders and 1 ureterosigmoidostomy case. The median (range) operative time was 230 (120-420) min and a total of 97 patients required blood transfusion. The median (ra...Continue Reading

References

Nov 1, 1985·The Journal of Urology·A OgawaM Nakama
Nov 20, 1997·The Journal of Urology·N StroumbakisW R Fair
Jun 19, 2001·Oncology Reports·R S LanceH B Grossman
Jun 8, 2002·World Journal of Surgery·Domenico D'UgoAurelio Picciocchi
Jul 13, 2002·Journal of Surgical Oncology·Frederick L Greene, Leslie H Sobin
Jan 22, 2004·European Urology·Michaël PeyromaureMarc Zerbib
Mar 16, 2004·Annual Review of Public Health·Eileen M Crimmins
Sep 12, 2006·European Urology·Giovanni LiguoriEmanuele Belgrano
Nov 4, 2006·International Urology and Nephrology·Kazuki YamanakaMasato Fujisawa
Feb 17, 2009·World Journal of Urology·Martine PloegLambertus A Kiemeney
Jun 2, 2009·European Urology·Michael FroehnerUrs E Studer
Nov 3, 2009·Urologic Oncology·Shahrokh F ShariatMichael J Droller
Mar 17, 2010·European Urology·Nathan LawrentschukManfred P Wirth
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
May 27, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Chen Jen ShanMiguel Srougi
May 27, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Erich K LangMichael Bergen
Jul 11, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Athanasios DellisAndreas Skolarikos
Sep 25, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alexander GreensteinNicola J Mabjeesh
Dec 3, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J SchiffmannP I Karakiewicz
Feb 11, 2015·Journal of Surgical Oncology·Ahmed S ZakariaArmen G Aprikian

❮ Previous
Next ❯

Citations

May 29, 2018·BJU International·Klaus EredicsStephan Madersbacher
Dec 14, 2017·Arab Journal of Urology·Matthew J YoungMohantha Dooldeniya
Apr 12, 2019·International Journal of Clinical Oncology·Katsuhiro ItoOsamu Ogawa
Nov 5, 2016·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alexander KretschmerAlexander Karl
May 26, 2017·BJU International·Cristian UdovicichDaniel Lenaghan
Sep 15, 2016·BJU International·Fiona C Burkhard, Patrick Y Wuethrich
May 26, 2017·BJU International·Nathan Lawrentschuk
Oct 23, 2018·Therapeutic Advances in Urology·Daniele CastellaniMarco Dellabella
Jan 23, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Niloy R DattaStephan Bodis
Feb 15, 2020·Journal of Geriatric Oncology·Nicolas MottetGeorgios Gakis
Jul 28, 2021·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A El AzabA Abdelbary

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.